Teracas chewable tablets 4 mg (Montelukast Sodium)

Adult dose

Adults and adolescents aged 15 years and older should take 10 mg of montelukast orally once daily. This medication should be administered 1 hour before meals or 2 hours after meals.

Child dose

Children aged 6 to 14 years should chew 5 mg of montelukast once daily. Children aged 2 to 5 years should chew 4 mg of montelukast once daily. This medication should be taken 1 hour before meals.

This medication may affect the nervous system and can cause symptoms such as restlessness, anxiety, depression, hallucinations, and suicidal thoughts, so careful monitoring for such changes is necessary during treatment. This medication contains the artificial sweetener aspartame, so patients with certain genetic disorders such as phenylketonuria should avoid taking it and limit their intake of aspartame. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Various adverse reactions such as fatigue, headache, abdominal pain, dyspepsia, cough, and rash may occur during treatment, so if abnormal symptoms persist, consult a doctor. This medication is not a fast-acting treatment for acute asthma attacks; therefore, appropriate emergency medications should always be prepared and used in emergencies. When used together with inhaled corticosteroid preparations, dosage adjustments should be made gradually under a doctor's guidance, and sudden changes should be avoided. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid using these medications while taking this drug. Rarely, serious vasculitis symptoms associated with eosinophilia may occur during treatment with this medication, so report any symptoms immediately to medical personnel. Drug interactions are rare, but caution is required when used with medications that induce certain liver metabolic enzymes, and it is advisable to consult a doctor. This medication should only be used in pregnancy when necessary, and breastfeeding individuals should consult a professional before taking it. Children and the elderly can also take this medication, but dosage adjustments and precautions based on age are necessary, and safety has not been established for children under 6 months of age. In the case of overdose, special antidotes are not available, so general treatment and observation according to symptoms are necessary. This medication should be kept out of the reach of children and should not be transferred to another container. If asthma symptoms worsen or new symptoms appear during treatment, consult a doctor immediately.

Serious side effects

• Hives
• severe swelling (edema)
• angioedema
• chest tightness
• difficulty breathing
• cold sweat
• paleness
• anaphylaxis
• toxic epidermal necrolysis
• Stevens-Johnson syndrome

Mild side effects

Restlessness, aggressive behavior, anxiety, depression, disorientation, attention deficit, speech stuttering, sleep disturbances and hallucinations, insomnia, memory impairment, obsessive-compulsive disorder, psychomotor hyperactivity (including irritability, instability, tremors), sleepwalking, tics, dizziness, drowsiness, perceptual disturbances/perceptual dullness, palpitations, nosebleeds, diarrhea, dyspepsia, nausea, vomiting, increased frequency of bleeding, thrombocytopenia, itching, rash, muscle pain, joint pain, enuresis, weakness/fatigue

This medication should be stored in a tightly sealed container to protect it from air and moisture. It should also be kept away from direct sunlight and stored at room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness and safety of the medication.

Appearance

Pink chewable tablet shaped like a convex oval on both sides

Package unit

28 tablets/box ((7 tablets/PTPX4))